Clinical Trials on Alopecia Areata in United Kingdom

Total 311 results

Callender Center for Clinical Research

Unknown

Safety and Efficacy of Clobetasol Propionate 0.05% E Foam in Alopecia

Alopecia

United States
Montefiore Medical Center
Sciton

Recruiting

1470nm Laser for the Treatment of Androgenetic Alopecia and Scarring Alopecia

Androgenetic Alopecia | Scarring Alopecia

United States
Allergan

Terminated

Safety, Tolerability, and Pharmacokinetics of Bimatoprost in Men With Androgenetic Alopecia (AGA)

Alopecia | Alopecia, Androgenetic | Baldness

United States
Wake Forest University Health Sciences

Recruiting

A Pilot Study of Revian Red All LED Cap as a Novel Treatment for Central Centrifugal Cicatricial Alopecia

Central Centrifugal Cicatricial Alopecia

United States
Wake Forest University Health Sciences

Withdrawn

Calcipotriol as a Novel Treatment for Central Centrifugal Cicatricial Alopecia (CCCA) (CCCA)

Central Centrifugal Cicatricial Alopecia

United States
CorEvitas

Enrolling by invitation

CorEvitas Alopecia Areata (AA) Safety and Effectiveness Registry

Alopecia Areata

United States
University Hospitals Cleveland Medical Center

Terminated

Needle-free Delivery of Intralesional Triamcinolone for Pediatric Alopecia Areata

Alopecia Areata

United States
Icahn School of Medicine at Mount Sinai

Completed

Pilot Study of the Safety and Efficacy of Apremilast in Subjects With Moderate to Severe Alopecia Areata

Alopecia Areata

United States
Columbia University
Locks of Love; Alopecia Areata Initiative - Gates Foundation

Completed

Pilot Study to Evaluate the Efficacy of Ruxolitinib in Alopecia Areata

Alopecia Areata

United States
University of Miami

Completed

Vytorin in the Treatment of Alopecia Areata

Alopecia Areata

United States
University of Minnesota

Completed

Response of Topical Capsaicin in Alopecia Areata

Alopecia Areata

United States
Allergan

Completed

Safety and Efficacy Study of Bimatoprost in the Treatment of Men With Androgenic Alopecia

Alopecia | Alopecia, Androgenetic | Baldness

United States, Germany
Northwestern University

Active, not recruiting

Effect of Low-Dose Oral Minoxidil as Treatment of Permanent Chemotherapy-Induced Alopecia

Permanent Chemotherapy-induced Alopecia

United States
Emma Guttman
Pfizer

Completed

Dual JAK1/TYK2 Inhibitor for Cicatricial Alopecia

Cicatricial Alopecia

United States
Kerastem Technologies, LLC

Completed

STYLE -- A Trial of Cell Enriched Adipose For Androgenetic Alopecia (STYLE)

Alopecia, Androgenetic

United States
Applied Biology, Inc.

Completed

Minoxidil Response Testing in Males With Androgenetic Alopecia

Androgenetic Alopecia

United States, Australia, India, Italy
Montefiore Medical Center
Paxman

Recruiting

Scalp Cooling for Chemotherapy-Induced Alopecia in Patients of Color

Alopecia

United States
M.D. Anderson Cancer Center
National Alopecia Areata Foundation

Active, not recruiting

Alopecia Areata Registry (NAAR)

Alopecia Areata | Alopecia Totalis | Alopecia Universalis | Autoimmune Hair Loss | Alopecia Partialis

United States
Wake Forest University Health Sciences

Not yet recruiting

Azelaic Acid as a Novel Treatment for Central Centrifugal Cicatricial Alopecia (CCCA) ((CCCA))

Central Centrifugal Cicatricial Alopecia

United States
Emma Guttman
Pfizer

Recruiting

Ritlecitinib for Cicatricial Alopecia

Cicatricial Alopecia

United States
Northwestern University

Terminated

PAI-1 Expression in Non-scarring Hair Loss

Androgenetic Alopecia | Alopecia Areata | Telogen Effluvium

United States
Wake Forest University Health Sciences
The Skin of Color Society

Recruiting

Treatment Results for Patients With Central Centrifugal Cicatricial Alopecia (CCCA): a Multicenter Prospective Study (CCCA)

Central Centrifugal Cicatricial Alopecia (CCCA)

United States
Memorial Sloan Kettering Cancer Center

Active, not recruiting

A Study of PRP Treatment for Hair Loss After Cancer Therapy in Women With Breast Cancer

Alopecia

United States
Icahn School of Medicine at Mount Sinai

Terminated

Efficacy of Hair Transplantation Compared With Hypodermic Needle Irritation in Alopecia Areata

Alopecia | Alopecia Areata | Balding

United States
Lexington International, LLC

Completed

Treatment of Androgenetic Alopecia in Males

Androgenetic Alopecia | Hair Loss | Male Pattern Baldness

United States
Soterios Ltd

Completed

A Phase 2 Placebo Controlled, Clinical Trial Designed to Assess the Efficacy, Safety and Dose Response Characterisation of STS01 for the Treatment of Mild-moderate Alopecia Areata (AA) (SOT01)

Alopecia Areata

United Kingdom
University of Alabama at Birmingham
Eli Lilly and Company

Not yet recruiting

A Study to Evaluate the Safety and Efficacy of Baricitinib in the Treatment of Frontal Fibrosing Alopecia (FFA)

Frontal Fibrosing Alopecia

United States
LEO Pharma

Completed

A Trial to Assess the Effect of Delgocitinib Cream 20 mg/g on the Molecular Signature, Safety, and Efficacy in Adults With Frontal Fibrosing Alopecia

Frontal Fibrosing Alopecia

United States
Bellevue Dermatology
Celgene

Unknown

Trial Evaluating the Efficacy of Apremilast for the Treatment of Frontal Fibrosing Alopecia

Frontal Fibrosing Alopecia

United States
Cassiopea SpA
ICON Clinical Research; Canfield Scientific Inc.; Ergomed PLC; Pharmapace Inc

Recruiting

A Study to Evaluate the Efficacy and Safety of Clascoterone Solution in Treatment of Male Pattern Hair Loss (SCALP2) (SCALP2)

Alopecia, Androgenetic

Germany, United States, Poland
Galderma R&D

Completed

Minoxidil 2% Solution and Botanical Hair Regimen in Women With Thinning Hair and Female Pattern Hair Loss/Androgenic Alopecia

Female Pattern Hair Loss, Androgenic Alopecia

United States
Technoderma Medicines Inc.
Therapeutics, Inc.

Completed

Study of TDM-105795 Following Topical Administration in Male Subjects With Androgenetic Alopecia

Alopecia, Androgenetic

United States
Johnson & Johnson Consumer and Personal Products...

Completed

A Study to Evaluate the Effectiveness and Safety of 5 Percent Minoxidil Foam in the Treatment of Male Pattern Hair Loss

Androgenetic Alopecia

United States
Aclaris Therapeutics, Inc.

Terminated

ATI-502 Topical Solution for the Treatment of Alopecia Areata (AA), Alopecia Universalis (AU) and Alopecia Totalis (AT)

Alopecia Areata | Alopecia Totalis | Alopecia Universalis

United States
Biosplice Therapeutics, Inc.

Completed

A Study of the Safety, Tolerability, and Efficacy of Topical SM04554 Solution in Male Subjects With Androgenetic Alopecia (AGA)

Androgenetic Alopecia

United States
Cassiopea SpA
ICON Clinical Research; Canfield Scientific Inc.; Ergomed PLC; Pharmapace Inc

Recruiting

A Study to Evaluate the Efficacy and Safety of Clascoterone Solution in Treatment of Male Pattern Hair Loss (SCALP1)

Alopecia, Androgenetic

United States, Georgia
AbbVie

Recruiting

A Study to Evaluate the Safety and Effectiveness of Upadacitinib Tablets in Adult and Adolescent Participants With Severe Alopecia Areata (Up-AA)

Alopecia Areata

United States, Australia, Japan, Puerto Rico, New Zealand, China, Canada, Brazil, United Kingdom
Lexington International, LLC

Completed

Treatment of Androgenetic Alopecia in Females, 9 Beam

Androgenetic Alopecia | Hair Loss | Female Pattern Baldness

United States
Emma Guttman

Completed

A Pilot Study of Tralokinumab in Subjects With Moderate to Severe Alopecia Areata

Alopecia Areata

United States
Tufts Medical Center
Pfizer

Withdrawn

Topical Crisaborole in Patients With Alopecia Areata

Alopecia Areata

United States
Icahn School of Medicine at Mount Sinai
Novartis

Terminated

A Study of Secukinumab for the Treatment of Alopecia Areata

Alopecia Areata

United States
University of Minnesota

Completed

Combined Restylane and Triamcinolone Acetonide Injections for the Treatment of Alopecia Areata

Alopecia Areata

United States
Columbia University
Locks of Love

Completed

Study To Evaluate The Efficacy Of Tofacitinib In Moderate To Severe Alopecia Areata, Totalis And Universalis

Alopecia Areata

United States
Columbia University

Withdrawn

A Clinical Trial to Evaluate the Efficacy of Abatacept in Moderate to Severe Alopecia Areata

Alopecia Areata

United States
Hordinsky, Maria K., MD
3M; National Alopecia Areata Foundation

Completed

Aldara for the Treatment of Extensive Alopecia Areata

Alopecia Areata

United States
Galderma R&D

Completed

Minoxidil 5% / Botanical Hair Regimen in Men With Thinning Hair and Male Pattern Hair Loss/Androgenic Alopecia

Male Pattern of Hair Loss, Androgenic Alopecia

United States
Concert Pharmaceuticals

Completed

Efficacy and Tolerability Study of Two Dosing Regimens of CTP-543 in Adults With Alopecia Areata

Alopecia Areata

United States, Canada
Ablon Skin Institute Research Center
Nutraceutical Wellness Inc.

Completed

Efficacy and Safety of a Nutraceutical Supplement With Standardized Botanicals in Women With Thinning Hair

Hair Thinning

United States
Emma Guttman
Regeneron Pharmaceuticals

Recruiting

Regeneron AA Multicenter (Dupilumab)

Alopecia Areata

United States
Yale University

Completed

Follicular Revival in Treatment-resistant Alopecia Areata: Evaluating Use of Micro-needling

Alopecia Areata

United States

Clinical Trials on Alopecia Areata in United Kingdom

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Ukraine

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations